Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines - News-Medical.Net

3/29/2022 12:00:00 AM3 years 1 month ago

A new study evaluated the waning efficacy of the COVID-19 ChAdOx1 and BNT162b2 vaccines over six months following the second dose.

A recent study posted to the medRxiv* preprint server evaluated the waning efficacy of the coronavirus disease 2019 (COVID-19) ChAdOx1 and BNT162b2 vaccines over six months following the second dose.… [+6389 chars]

full article...